| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
8-K
| Quarterly results |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 07/26/2023 |
8-K
| Quarterly results |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2023 |
4
| Maraoui Claude (President & CEO) has filed a Form 4 on Journey Medical Corp|
Txns:
| Sold 20,000 shares
@ $1.25, valued at
$25k
Sold 24,377 shares
@ $1.34, valued at
$32.7k
|
|
| 05/16/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/30/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/29/2023 |
8-K
| Quarterly results |
| 03/01/2023 |
4/A
| De Paolantonio Ernest Robert (See Remarks) has filed a Form 4 on Journey Medical Corp|
Txns:
| Sold 10,093 shares
@ $2.41, valued at
$24.3k
|
|
| 02/23/2023 |
4
| Benesch Joseph (Interim CFO) has filed a Form 4 on Journey Medical Corp|
Txns:
| Sold 2,768 shares
@ $1.97, valued at
$5.5k
|
|
| 01/31/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/27/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/20/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 12/30/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 12/29/2022 |
SC 13G/A
| B. Riley Financial, Inc. reports a 4.9% stake in Journey Medical Corporation |
| 10/06/2022 |
4
| De Paolantonio Ernest Robert (CFO) has filed a Form 4 on Journey Medical Corp|
Txns:
| Sold 10,093 shares
@ $2.41, valued at
$24.3k
|
|
| 08/17/2022 |
SC 13G
| Fortress Biotech, Inc. reports a 56.9% stake in Journey Medical Corporation |
| 07/25/2022 |
4
| ROSENWALD LINDSAY A MD (Director) has filed a Form 4 on Journey Medical Corp|
Txns:
| Granted 14,245 shares
@ $0 |
|
| 07/25/2022 |
4
| Smith Justin Adam (Director) has filed a Form 4 on Journey Medical Corp|
Txns:
| Granted 14,245 shares
@ $0 |
|
| 07/25/2022 |
4
| Paley Jeffrey (Director) has filed a Form 4 on Journey Medical Corp|
Txns:
| Granted 14,245 shares
@ $0 |
|
| 07/25/2022 |
4
| Herskowitz Neil (Director) has filed a Form 4 on Journey Medical Corp|
Txns:
| Granted 14,245 shares
@ $0 |
|
| 07/25/2022 |
4
| Toledano Miranda Jayne (Director) has filed a Form 4 on Journey Medical Corp|
Txns:
| Granted 14,245 shares
@ $0 |
|
| 07/25/2022 |
4
| Maraoui Claude (President & CEO) has filed a Form 4 on Journey Medical Corp|
Txns:
| Granted 300,000 shares
@ $0 |
|
| 07/25/2022 |
4
| De Paolantonio Ernest Robert (CFO) has filed a Form 4 on Journey Medical Corp|
Txns:
| Granted 150,000 shares
@ $0 |
|
|